Defective class II transactivator expression in a B lymphoma cell line.
D045744:Cell Line, Tumor; D004252:DNA Mutational Analysis; D018076:DNA, Complementary; D015972:Gene Expression Regulation, Neoplastic; D005802:Genes, MHC Class II; D005816:Genetic Complementation Test; D006681:HLA-D Antigens / Q000235:genetics; D006801:Humans; D016393:Lymphoma, B-Cell / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D015534:Trans-Activators / Q000235:genetics*; D014158:Transcription, Genetic
D018076:DNA, Complementary; D006681:HLA-D Antigens; C083728:MHC class II transactivator protein; D009687:Nuclear Proteins; D015534:Trans-Activators